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Abstract
Membrane proteins play key roles in many biological processes, from acquisition of nutri-
ents to neurotransmission, and are targets for more than 50% of current therapeutic drugs.
However, their investigation is hampered by difficulties in their production and purification
on a scale suitable for structural studies. In particular, the nature and location of affinity tags
introduced for the purification of recombinant membrane proteins can greatly influence their
expression levels by affecting their membrane insertion. The extent of such effects typically
depends on the transmembrane topologies of the proteins, which for proteins of unknown
structure are usually uncertain. For example, attachment of oligohistidine tags to the peri-
plasmic termini of membrane proteins often interferes with folding and drastically impairs
expression in Escherichia coli. To circumvent this problem we have employed a novel strat-
egy to enable the rapid production of constructs bearing a range of different affinity tags
compatible with either cytoplasmic or periplasmic attachment. Tags include conventional
oligohistidine tags compatible with cytoplasmic attachment and, for attachment to proteins
with a periplasmic terminus, either tandem Strep-tag II sequences or oligohistidine tags
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fused to maltose binding protein and a signal sequence. Inclusion of cleavage sites for TEV
or HRV-3C protease enables tag removal prior to crystallisation trials or a second step of
purification. Together with the use of bioinformatic approaches to identify members of mem-
brane protein families with topologies favourable to cytoplasmic tagging, this has enabled
us to express and purify multiple bacterial membrane transporters. To illustrate this strat-
egy, we describe here its use to purify bacterial homologues of human membrane proteins
from the Nramp and ZIP families of divalent metal cation transporters and from the concen-
trative nucleoside transporter family. The proteins are expressed in E. coli in a correctly
folded, functional state and can be purified in amounts suitable for structural investigations.
Introduction
Membrane proteins account for 20–30% of the genes in most sequenced genomes [1,2]. They
perform many functions essential to the life of cells, ranging from uptake of nutrients to infor-
mation transfer, and their malfunction is implicated in a wide range of diseases [3]. In addition
to their roles in normal physiology, they also represent approximately 60% of current therapeu-
tic drug targets [4,5]. Gaining a detailed understanding of their molecular mechanisms requires
high resolution structural information, but at present relatively few membrane protein struc-
tures have been solved: in May 2015 the Protein Databank included only about 1,654 mem-
brane protein structures, compared to more than 90,000 structures of water-soluble proteins.
In large part this reflects the difficulty of expressing and purifying these amphipathic proteins
and maintaining them in a sufficiently stable state for biophysical and structural studies [6,7].
The majority of membrane protein structures to date are of prokaryotic origin, although an
increasing number of structures have been determined for eukaryotic proteins expressed in
yeast, insect or mammalian cells [6]. Although E. coli has proven to be a robust expression host
for recombinant expression of prokaryotic membrane proteins [8], heterologous expression
can result in poor expression levels or production of misfolded protein, either within the mem-
brane or in the form of inclusion bodies [9,10]. A known source of such problems is the effect
of added affinity tags on the membrane insertion and folding of the proteins, probably reflect-
ing the importance of the charges present in the cytoplasmic and non-cytoplasmic regions
flanking transmembrane segments in the correct biosynthesis of α-helical membrane proteins
[11,12]. For example, we have shown that attachment of oligohistidine tags to the periplasmic
termini of membrane proteins drastically impairs their production in E. coli, while similar
attachment to cytoplasmic termini is well tolerated [13].
While Nin-Cin topologies dominate the membrane proteomes of most organisms, one or
both termini of a substantial fraction of membrane proteins are located on the extracellular/
periplasmic side of the membrane [1]. A variety of approaches has been adopted for the pro-
duction and purification of such proteins, including attachment of Strep-tag II sequences to
periplasmic C-termini [13] and attachment of an N-terminal maltose binding protein (MBP)
preceded by a signal sequence, enabling translocation of an oligohistidine tag across the mem-
brane [14]. In a novel approach, Quick andWright attached an additional transmembrane
helix from glycophorin A to the C-terminus of the human sodium-linked glucose transporter
hSGLT1 to bring its C-terminus to the cytoplasmic side of the membrane, allowing overexpres-
sion of functional, His-tagged protein in E. coli [15]. The same approach was more recently
employed as a generic strategy to convert membrane proteins with a Cout topology to a Cin
topology, allowing use of C-terminally attached GFP as a reporter of expression and folding
[16]. However, for membrane proteins of unknown structure the location of the termini
cannot usually be predicted with 100% accuracy, in part because the algorithms employed for
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prediction of topology typically do not take into account the substantial changes in protein
folding that may occur subsequent to insertion of individual transmembrane segments into the
membrane, and the effects of neighbouring helices on the insertion of a marginally hydropho-
bic transmembrane helix [17]. It is therefore usually necessary to test a variety of constructs,
bearing different tags and employing different promoters, together with a range of expression
strains, in order to identify conditions suitable for production of the amounts of correctly
folded, functional protein required for structural and other studies.
To facilitate the rapid investigation of multiple expression conditions, we have previously
described the use of autoinduction in deep well plates to optimise expression of constructs
encoding membrane proteins [18]. In that study, the proteins tested had at least one cyto-
plasmic terminus, to which affinity tags were attached. To extend this approach to membrane
protein families whose members possess extracytoplasmic termini, we describe here two new
strategies for the rapid identification of constructs/conditions yielding good expression, what-
ever the topology of the original target of interest.
Our first strategy was to use bioinformatic analyses to identify transporters that differ from
the majority of members of the cognate protein family in possessing an additional putative
transmembrane segment, thus bringing either the N- or C-terminus of the protein to the cyto-
plasmic side of the membrane. Such proteins are compatible with attachment of standard affin-
ity tags such as oligohistidine.
Our second strategy was to create a new family of expression vectors optimised for “out”
expression. We have exploited restriction sites less commonly found in prokaryote genomic
DNA to create a family of expression vectors between which open reading frames (ORFs) can
readily be exchanged. In addition to tags previously employed [13,18], these vectors include
ones, such as tandem Strep-tag II sequences and MBP preceded by a signal sequence, that are
compatible with attachment to the extracytoplasmic termini of membrane proteins. The tighter
binding of Streptactin to the tandem Strep-tag II than the single Strep-tag II [19] allows purifi-
cation of membrane proteins to near homogeneity in a single step.
Our test cases were prokaryotic members of three families of membrane transporters of bio-
medical importance where one or both termini are typically extracytoplasmic. The families stud-
ied were: the concentrative nucleoside transporter (CNT) family of cation/nucleoside co-
transporters [20] with an Nout-Cout topology [21,22], and two families of divalent metal ion trans-
porters: the “Zrt, Irt-like Protein” (ZIP) family, also with an Nout-Cout topology [23], and the
“Natural Resistance-associatedMacrophage Protein” (Nramp) [24], with an Nin-Cout topology. A
total of five prokaryotic transporters representative of these families were successfully expressed
in E. coli using these approaches and purified to near homogeneity in sufficient amounts and
with a monodispersity in detergent solution necessary for subsequent biochemical investigations.
Assays showed that all but one of the expressed proteins were functionally active. Interest-
ingly the two members of the ZIP family investigated proved to have channel-like properties
with zinc ion, while the member of the Nramp family investigated, from Enterococcus faecalis,
predicted to be an iron or manganese transporter [25,26], appears to be a zinc transporter. The
strategies described in this study should prove generally useful for the production of membrane
proteins with difficult topologies for biophysical and biochemical studies.
Materials and Methods
Materials
Genomic DNA for Pseudomonas fluorescens Pf-5 was obtained from ATCC, while genomic
DNAs from Enterococcus faecalis strain V583 and Vibrio cholerae strain N16961 were kindly
provided by the Department of Microbiology, University of Leeds, and by the University of
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York, respectively. Genomic DNA for Achromobacter xylosoxidans was prepared from strain
NCIMB 11015, while the ORF of the ZIP family member CB-ZIP from Coxiella burnetii was
synthesised by GenScript USA Inc. (Piscataway, NJ 08854, USA), following optimisation by
the JCat method [27] for expression in E. coli. Phospholipids were obtained from Avanti Polar
Lipids Inc. (Alabaster, AL, USA), while the detergents n-dodecyl-β-D-maltoside (DDM) and
n-decyl-β-D-maltoside (DM) were from GLYCON Biochemicals GmbH (Luckenwalde, Ger-
many) and lauryldimethylamine-N-oxide (LDAO) and octaethylene glycol monododecyl ether
(C12E8) were from Anatrace (Maumee, USA). HisPur™ Cobalt resin was from Perbio Science
UK Ltd. (Cramlington, UK) and Ni2+-NTA Agarose was from Generon Ltd. (Maidenhead,
UK), while PD-10 desalting and Hitrap Q HP columns were from GE Healthcare (Little Chal-
font, UK). Centrifugal concentrators were obtained from Sartorius Stedim Biotech. Plasmids
pET26 and pCR1-Blunt were obtained from Novagen (Millipore (UK) Ltd.) and Invitrogen
(Life Technologies Ltd., Paisley, UK) respectively. An N-terminally hexahistidine-tagged form
of TEV protease, encoded by pTH24:TEVSH [28] and an N-terminally octahistidine-tagged
form of HRV-3C protease, encoded by a pET28 derivative, were purified by immobilised metal
affinity chromatography (IMAC) following expression in E. coli. Strep-Tactin1 Superflow1
resin and Strep-tag1 II specific monoclonal antibody were obtained from IBA GmbH (Goet-
tingen, Germany) and HRP-labelled monoclonal anti-His-tag antibodies (Clone # AD1.1.10)
from R&D Systems Europe Ltd. (Abingdon, UK). COmplete1 EDTA-free protease inhibitor
cocktail tablets were obtained from Roche Applied Science. [5,6-3H]Uridine (39.5 Ci/mmol)
was obtained from PerkinElmer Life Sciences Ltd, UK and FluoZin™-1 from Life Technologies
Ltd. (Paisley, UK).
Expression trials
Expression trials were typically performed in four E. coli strains in parallel: BL21-gold(DE3)
(Stratagene), BL21 StarTM (DE3) (Invitrogen; [29]), C41(DE3) and C43(DE3) (Lucigen Corpo-
ration; [30]), all of which had been transformed with the plasmid pRARE2 (Novagen) to
enhance translation efficiency of ORFs with codon usage different from endogenous E. coli
genes [31]. Typically, autoinduction of 1 mL cultures in modified M9 medium (M9auto); Lysog-
eny broth (LBauto) or Superbroth medium (SBauto) containing 0.5% glycerol, 0.05% glucose and
0.2% lactose was performed at 37°C for 24 h in 24-deep-well plates as previously described
[18]. Cell lysates were prepared in buffer containing 1% Triton X-100 and 0.1 mg mL-1 lyso-
zyme and their protein concentrations measured using the bicinchoninic acid (BCA) assay
(Perbio Science UK Ltd). Samples were then analysed by SDS-12% (w/v) polyacrylamide gel
electrophoresis (SDS-PAGE) followed by staining with Coomassie Brilliant Blue R250 (Fluka)
or by western blotting using either horseradish peroxidase-labelled monoclonal antibody
against oligohistidine tags or the Strep tag II sequence as appropriate [18]. For quantification of
His-tagged constructs, known amounts of a hexahistidine-tagged form of TEV protease [28]
were included on the gel. Following incubation with SuperSignal1West Pico chemilumines-
cent substrate (Perbio Science UK Ltd), signals were detected and quantified using a GeneG-
nome Detection system and GeneTools software, respectively (Syngene Bio Imaging).
Large scale expression and membrane preparation
For preparative scale membrane production cultures were grown in flasks on a 4 L scale, or in a
fermenter on a 30 L scale, essentially as previously described [18], using the optimum combina-
tion of host strain and medium for each target, established as described above. Typically, cul-
tures were autoinduced for 24 h at 37°C. In the case of CNT constructs, where autoinduction
was less effective, cultures were instead induced with 0.5 mM isopropyl β-D-thiogalactoside
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(IPTG) when a OD600nm value of 0.7 was reached, and then incubated for a further 3 h (for
Strep-tagged constructs) or 6 h (for MBP-tagged constructs) at 37°C. Following harvesting by
centrifugation, cells were suspended at a concentration of 5–6 mL/g wet weight in Tris-EDTA
buffer (20 mM Tris, 0.5 mM EDTA, pH 7.4 at 4°C) containing protease inhibitor (cOmplete1
EDTA protease inhibitor cocktail tablets, Roche Applied Science, 1 tablet per 50 mL solution).
They were then disrupted at 30 Kpsi using a TS series 2.2 KW continuous cell disruptor (Con-
stant Systems Ltd., UK) and membranes were prepared by centrifugation as previously
described. The latter were stored at -80°C at a concentration of 20–40 mg/mL in 20 mM Tris-
HCl, pH 7.4 at 4°C, or in phosphate-buffered saline (PBS; 10 mM Na2HPO4, 1.8 mM KH2PO4,
137 mMNaCl, 4 mM KCl, pH 7.4).
Detergent solubilisation and purification of affinity-tagged transport
proteins
All stages of detergent solubilisation and protein purification were performed at 4°C unless
otherwise stated.
Solubilisation trials
Solubilisation trials were performed using E. colimembranes, harbouring the desired target
protein, at a concentration of 5 mg/mL in 100 μL solubilisation buffer (50 mMHEPES, pH 7.4,
150 mMNaCl, 5% (w/v) glycerol) containing 5 mM imidazole and 0, 0.33, 1, or 1.5% detergent
(DDM, DM, LDAO or C12E8). Samples were gently mixed for 2 h and then centrifuged at
100,000 gav for 1 h. Samples of the mixture taken before centrifugation and of the supernatant
were then subjected to analysis by western blotting. Following identification of the optimum
solubilisation conditions these were then used to purify the individual target proteins as fol-
lows. All steps were performed at 4°C.
Purification of double Strep-tagged CNTs
For purification of Strep-tagged CNTs, membranes (140 mg protein) were suspended at a con-
centration of 2 mg/mL in buffer 8 (Table 1) containing cOmplete protease inhibitor cocktail
and 1% DDM. After incubation for 1 h the mixture was centrifuged at 100,000 gav for 1 h to
remove insoluble material and then the supernatant was diluted with an equal volume of buffer
9 (Table 1). It was then incubated overnight with 0.5 mL Strep-Tactin1 Superflow1 resin,
with gentle mixing. After transfer to a column, the resin was next washed with 5 mL Buffer 10
(Table 1) containing 0.05% DDM. Fractions (0.5 mL) were then collected during passage
through the column of Buffer 10 (Table 1) containing 2.5 mM d-desthiobiotin and 0.05%
DDM. Fractions containing eluted protein, as assessed by their A280nm values, were pooled and
dialysed against Buffer 10 containing 0.05% DDM to remove desthiobiotin.
Purification and proteolytic cleavage of MBP-tagged CNTs
For purification of MBP-tagged CNTs, membranes (100 mg protein) were suspended at a con-
centration of 2 mg/mL in Buffer 11 (Table 1) containing cOmplete, EDTA-free protease inhibi-
tor cocktail and 1% DDM. After incubation for 1 h the mixture was centrifuged at 100,000 gav
for 1 h to remove insoluble material and the supernatant was then incubated with 4.0 mL His-
Pur™ Cobalt Resin overnight with gentle shaking. After transfer to a column, the resin was next
washed with 40 mL Buffer 11 containing 5 mM imidazole and 0.05% DDM. Fractions (4 mL)
were then collected during passage through the column of Buffer 12 containing 0.05% DDM
and those containing eluted protein, as assessed by their A280nm values, were pooled.
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To remove the MBP tag, His-tagged HRV-3C protease added to the pooled fractions at a
molar ratio of protease to protein of 1:15, followed by dialysis overnight against Buffer 13 con-
taining 1 mMDTT and 1 mM uridine. Following subsequent incubation for 3 h at 10°C the
digestion mixture was dialysed against Buffer 14 and then passed through a column (4.0 mL)
of Ni-NTA agarose to remove the protease and MBP. The purified protein was then concen-
trated to 2 mg protein/mL using a 100 kDa cut-off centrifugal filter.
Purification of MBP-tagged CBZIP
For purification of MBP-tagged CBZIP, membranes (200 mg) were solubilised by incubation
for 1 h at a final concentration of 5 mg/mL in Buffer 16 (Table 1) containing 10 mM imidazole,
1% DM and 1 tablet cOmplete1 EDTA-free protease inhibitor cocktail per 50 mL.Following
centrifugation at 110,000 gav for 1 h to remove insoluble material the supernatant was incu-
bated with 4 mL HisPur™ Cobalt Resin for 2 h.
After transfer to a column, the resin was next washed with 30 mL Buffer 16 containing 20
mM imidazole and 0.2% DM followed by 30 mL. of the same buffer containing 40 mM and
0.2% DM. Finally, the protein was eluted in batch with 12 mL solubilisation buffer 17 (Table 1)
containing 200 mM imidazole and 0.2% DM. The eluted material was dialysed overnight
against Buffer 17 containing 0.2% DM, concentrated to 1 mg protein/mL using a 100 kDa cut-
off centrifugal filter.
Purification of N-terminally His-tagged AXZIP
For purification of AXZIP, membranes (100 mg) were solubilised by incubation for 1 h at a
final concentration of 5 mg/mL in Buffer 16 (Table 1) containing 10 mM imidazole, 1.0% DM
and 1 tablet cOmplete1 EDTA-free protease inhibitor cocktail per 50 mL. Following centrifu-
gation at 110,000 gav for 1 h to remove insoluble material the supernatant was incubated with
2.0 mL HisPur™ Cobalt Resin for 2 h with gentle shaking. The unbound material was then
Table 1. Buffers.
Buffer
name
HEPES
(mM)
Bis-Tris
(mM)
MES
(mM)
Tris
(mM)
KPi
(mM)
pH NaCl
(mM)
K2SO4
(mM)
EDTA
(mM)
Glycerol (w/v;
%)
Buffer 1 50 8.0 150 20
Buffer 2 50 7.4 150 5
Buffer 3 50 6.0 5
Buffer 4 50 6.0 1000 5
Buffer 5 50 6.0 5
Buffer 6 2 2 6.8
Buffer 7 20 20 6.8 50
Buffer 8 50 7.0 100 1
Buffer 9 50 7.0 100 1 10
Buffer 10 50 7.0 100 1 5
Buffer 11 50 7.4 150 10
Buffer 12 50 6.0 300 10 20
Buffer 13 50 8.0 150 1 5
Buffer 14 50 8.0 150
Buffer 15 20 7.9 300 20
Buffer 16 50 8.0 300 20
Buffer 17 50 8.0 300 5
doi:10.1371/journal.pone.0143010.t001
Production of Membrane Proteins with Diverse Topologies
PLOS ONE | DOI:10.1371/journal.pone.0143010 November 25, 2015 6 / 23
removed by passage through a column with a filter and then the resin washed by passage of
30 mL Buffer 16 containing 10 mM imidazole and 0.2% DM and then with 30 mL portions of
Buffer 15 containing 20 mM and 40 mM imidazole respectively. Finally, the resin was eluted
with 12 mL Buffer 15 containing 0.2% DM and 200 mM imidazole. The eluted material was
dialysed overnight against Buffer 17 (Table 1) containing 0.2% DM and then concentrated to
1 mg protein/mL using a 100 kDa cut-off centrifugal filter.
Purification of C-terminally His-tagged MntH2
For purification of MntH2, membranes (300 mg) were solubilised by incubation for 1 h at a
final concentration of 5 mg/mL in Buffer 1 (Table 1) containing 10 mM imidazole (pH 8.0),
1.5% DDM and 1 tablet cOmplete1 EDTA-free protease inhibitor cocktail per 50 mL. Follow-
ing centrifugation at 110,000 gav for 1 h to remove insoluble material the supernatant was incu-
bated with 16 mL HisPur™ Cobalt Resin for 2 h with gentle shaking. The unbound material was
then removed by passage through a column with a filter and then the resin washed by passage
of 160 mL Buffer 1 containing 20 mM imidazole and 0.05% DDM and then with 96 mL of
Buffer 1 containing 40 mM and 80 mM imidazole respectively. Finally, the resin was eluted
with 48 mL Buffer 2 (Table 1) containing 0.05% DDM and 200 mM imidazole. The eluted
material was dialysed overnight against Buffer 3 (Table 1) containing 0.05% DDM, concen-
trated to 3 mg protein/mL using a 100 kDa cut-off centrifugal filter, then further purified by
anion exchange chromatography on a 1 mL Hitrap Q HP column (GE Healthcare). After appli-
cation of the sample the column was eluted with a gradient (20 mL) of 0–100% Buffer 4
(Table 1) containing 0.05% DDM. The peak fractions of eluted material, as judged by their
A280nm values, were combined, dialysed against Buffer 5 (Table 1) containing 0.05% DDM,
concentrated again to about 10 mg/mL, flash frozen in liquid nitrogen and then stored at
-80°C.
Transport assays
Measurements of uridine uptake by IPTG-induced E. coli cells harbouring vectors encoding
CNTs were performed at 25°C as described previously for the bacterial nucleoside transporter
NupG [32]. [5,6-3H]Uridine was used at a final concentration of 50 μM and at a specific radio-
activity of 1–5 mCi/mmol.
Assays of zinc uptake into reconstituted proteoliposomes harbouring ZIP or Nramp family
transporters were performed essentially as described by Chao and Fu [33]. In brief, small unila-
mellar liposomes (50 mg/mL) were prepared from E. coli polar lipids by sonication in Buffer 6
(Table 1) containing 2 mM 2-mercaptoethanol (2-ME). A reconstitution mixture (1 mL) was
then prepared by mixing 6.5 mg liposomes with 0.2–0.4 mg purified transporters plus sufficient
n-octyl-β-D-glucoside (β-OG) to give a final concentration of 1% (w/v) in Buffer 7 (Table 1)
containing 2 mM 2-ME. Following incubation at 20°C for 20 min to ensure complete solubili-
sation of lipids, reconstitution of proteoliposomes was achieved by passage through a PD-10
desalting column, pre-equilibrated with Buffer 7 (Table 1). The cloudy void volume fraction
was centrifuged at 140,000 gav for 45 min to pellet the proteoliposomes, which were then resus-
pended in 200 μL Buffer 7. Control liposomes were prepared following exactly the same proce-
dure but without addition of protein. The proteoliposomes and control liposomes were then
loaded with the Zn2+-sensitive indicator FluoZin™-1 at a final indicator concentration of
200 μM by bath sonication (10 s), freeze-thawing in liquid nitrogen and then an additional 10 s
sonication. Proteoliposomes containing entrapped indicator were then separated from free
indicator by passage through a second PD-10 desalting column, pre-equilibrated with Buffer 7.
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Kinetic experiments were performed in fluorescence mode on a stopped-flow apparatus
(Applied Photophysics Ltd., Leatherhead, UK) at 20°C. Proteoliposome samples and Buffer 7
containing the desired concentration of ZnCl2 (0–4 mM) were loaded into two separate mixing
syringes of equal volume, and transport reactions were initiated by pushing 1 mL of fresh reac-
tants at a 1:1 ratio through the 100 μL mixing cell. For measurements of fluorescence changes,
samples were excited at 490 nm, and emission was monitored using a filter with a cut-off wave-
length of 515 nm. The base-line fluorescence was set by flushing reactants through the mixing
cell and adjusting the photomultiplier tube voltage to a level that would give a 1 V signal in the
middle of the -5 –+5 V detectable range. The Kd for zinc binding to FluoZin™-1 is 8 μM, such
that at the concentration of indicator employed (200 μM) there will be an approximately linear
fluorescent response (ΔF) to the total intravesicular zinc concentration. The fluorescence
response ΔF was normalised to the maximum fluorescence change ΔFmax obtained upon
release of the encapsulated indicator to 2 mM Zn2+ by addition of 1% β-OG, representing the
total vesicle loading with FluoZin™-1. This yielded the dimensionless fluorescence change ΔF/
ΔFmax, which was plotted as a function of time.
Circular dichroism spectroscopy
Circular Dichroism (CD) spectroscopy measurements were typically performed at 20°C using
a Chirascan CD spectrometer (Applied Photophysics Ltd.) with continuous nitrogen purging.
Samples (0.25–0.5 mg/mL) in the corresponding stocking buffers as mentioned above were
analysed in Hellma quartz cuvettes of path lengths 0.1 or 0.01 cm. Each spectrum represented
the average of at least 2 scans from 180 nm to 260 nm. Spectra were recorded at a speed of 1
nm/s, bandwidth 1 nm. CD data were analyzed using DichroWeb [34,35]. To examine their
thermal stability, CD spectra from 180 nm to 260 nm were recorded at a speed of 1 nm/0.3s
during the heating of purified proteins from 10°C to 90°C at a rate of 1°C per min. To estimate
the melting temperature, the resultant data were fitted to the Boltzmann equation for a sigmoid
curve using Origin8 (OriginLab corporation, Northampton, USA).
Results
Rationale behind target selection
We have previously demonstrated that attachment of N- or C-terminal oligohistidine tags is
the best approach for expressing and purifying prokaryotic membrane proteins in E. coli [13]
as long as both the N- and C-terminus are cytoplasmic. In this study, we specifically chose
three protein families where one or both termini are predicted to be periplasmic, and used
BlastP searches of the UniProt protein sequence database to ascertain whether any family
members possessed topologies more suitable for tagging, i.e. where the termini were located on
the cytoplasmic side of the membrane.
While eukaryotic members of the Nramp family have an Nin-Cin topology with 12 TM seg-
ments [24], the E. colimember MntH has only 11 TM segments such that the C-terminus is
located on the extracellular/periplasmic side of the membrane [36], as do most of the other
prokaryotic Nramp family members identified by BlastP searches. However, an Nramp from
Lactobacillales had an additional hydrophobic, poorly-conserved region near the C-terminus
that was predicted to be membrane-spanning using the TMHMM2.0 [1], PHOBIUS [37] and
TOPCONS [38] programs (Fig 1A). This would place the C-terminus on the cytoplasmic side
of the membrane. We chose one such protein for investigation, MntH2 from Enterococcus fae-
calis (UniProt accession Q836Q1).
For the Zip family, almost all prokaryotic and eukaryotic family members are predicted to
possess an 8TM, Nout-Cout topology [22] (Fig 1C), which has been experimentally confirmed
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for human ZIP13 [39]. Our BlastP searches identified a few members of the family from the
Proteobacteria, in the GufA subfamily (S1 Fig), that possessed an additional hydrophobic,
poorly-conserved region near the N-terminus. Sequence analysis [1,37,38] again suggested that
this was membrane-spanning (Fig 1B) but that it was not a signal sequence, unlike in some
eukaryotic family members [23]. The N-termini of the proteins would be located on the cyto-
plasmic side of the membrane. We thus chose two such proteins, one from Pseudomonas fluor-
escens (UniProt accession Q4K7I2), PFZIP, and one from Achromobacter xylosoxidans
(UniProt accession V9S2P1), AXZIP. We also included a third prokaryotic ZIP protein, from
Coxiella burnettii (CBZIP), for two reasons. First, it belongs to ZIP subfamily II, as opposed to
ZIP subfamily I, and thus constitutes a good model for investigation of structure/function rela-
tionships in this group of transporters (Fig 1C). This is the most common of the ZIP subfami-
lies in mammals. Second, like all other ZIP subfamily II members, it is predicted to have the
most difficult topology: Nout-Cout, thus providing the most stringent test of our new vector
system.
Eukaryotic members of the CNT family have an Nin-Cout topology, while their prokaryotic
counterparts lack three N-terminal TM helices and so possess an Nout-Cout topology [21,22,40]
(Fig 1). Despite extensive searches, we did not find any prokaryotic CNTs with other topolo-
gies. We therefore chose two prokaryotic targets (Fig 1D): VcCNT, a sodium-dependent nucle-
oside transporter from Vibrio cholera, and NupC, a proton-dependent nucleoside transporter
from E. coli, the function of which has been well characterised but for which no structural
information is currently available [41,42]. These proteins have about 25% sequence identity to
their human counterparts, hCNT1-3 [22].
Fig 1. Putativemembrane topology of studied transporters: (A) MntH2 from the Nramp family, (B) AXZIP, PFZIP from the ZIP family, (C) CBZIP, GSZIP,
DVZIP from the ZIP family and (D) EcNupC, VcCNT, from the CNT family investigated in the present study. The TMs of the human homologues are shown in
black. The putative additional TM helixes are shown in white.
doi:10.1371/journal.pone.0143010.g001
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MntH2, AXZIP and PFZIP thus represent our model proteins for expression and purifica-
tion of membrane proteins with at least one terminus in the cytoplasm, while CBZIP, NupC
and VcCNT have been chosen as examples of expression and purification of membrane pro-
teins with both termini in the periplasm.
Generation of expression vectors
To facilitate the rapid screening of expression constructs bearing different affinity tags, and to
compare the use of different promoters, we cloned target ORFs, flanked by suitable restriction
sites, into the vector pCR-Blunt1 (Invitrogen) to generate entry vectors. Restriction sites cho-
sen were AvrII and SbfI, because these occur relatively infrequently in many bacterial genomes
and so are less commonly found within target ORFs than, for example, EcoRI sites. If sites are
endogenously present within the ORFs, a number of compatible sites are available as alterna-
tives in each case. Primers used for amplification of the targets used in the present study, and
for subsequent DNA sequencing (Source BioScience, Nottingham, UK) to verify the sequences
of the ORFs and flanking regions in entry and expression vectors, are listed in S1 Table. The
target ORFs were then subcloned into a range of expression vectors (Fig 2) bearing the same or
compatible restriction sites, which facilitated not only transfer from the entry vector but
exchange of ORFs between different expression constructs. Two types of expression vectors
were generated for the present study, using as a backbone either pTTQ18, in which expression
is under the control of the tac promoter [43], or a pET vector which employs a T7 promoter
[44]. A subset of the vectors constructed for the present project include cleavage sites for the
highly selective Tobacco Etch Virus (TEV) protease or Human Rhinovirus 3C (HRV-3C) pro-
tease, enabling tag removal prior to crystallisation, if necessary. In addition, inclusion of such
sites enables a second purification step following cleavage, for example to remove endoge-
nously His-rich E. coli proteins such as AcrB [45]. In contrast to TEV protease, which we previ-
ously exploited [18], HRV-3C protease retains substantial activity at 4°C [20] and so is ideal for
cleavage of temperature-sensitive membrane proteins in detergent solution.
Expression and purification of transporters with at least one cytoplasmic
terminus
The Nramp family transporter MntH2: both termini in. As described above, MntH
from E. faecalis is predicted to have a 12 TM, Nin-Cin topology (Fig 1). It is thus a better model
for eukaryotic members of the family, which exhibit a similar 12 TM topology. The predicted
“additional” 12th TM segment should allow use of a conventional His tag. To test this, we made
three constructs: with a C-terminal RGSH8 tag alone (pL31-MntH2), with a TEV cleavage site
(pL32-MntH2), or with an HRV-3C (pL33-MntH2) cleavage site. Preliminary expression trials
(data not shown) on pL31-MntH2 were consistent with Cin topology: autoinduction in E. coli
strain BL21 Star™ (DE3) in SB medium for 24 h yielded good expression, and so these condi-
tions were used to compare the expression of the three constructs. Western blots of induced
cell lysates stained by antibodies against the His-tag revealed a major band of size ~ 50 kDa in
each case (Fig 3A). The difference in the mobility of this band and the predicted sizes of the
tagged proteins (60.3, 61.5 and 61.4 kDa respectively) likely reflects the anomalous mobility of
integral membranes on SDS-PAGE [46].
ZIP family proteins with only N-terminus in. P. fluorescens PFZIP and A. xylosoxidans
AXZIP are predicted to have a 9TM, Nin-Cout topology, so it should be possible to attach a His-
tag to the cytoplasmic N-terminus. We therefore made constructs encoding proteins with dif-
ferent N-terminal tags: RGSH8 (pL21-PFZIP and pL21-AXZIP), Strep-tag II sequence and a
GSH8 tag plus a TEV cleavage site (pL26-PFZIP and pL26-AXZIP) (Fig 2). Expression trials on
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these showed very high levels of expression (~ 15 mg/L culture) using pL26-PFZIP following
24 h auto-induction at 37°C in SB medium in the C43(DE3):pRARE2 E. coli strain (data not
shown). However, we were unable to solubilise it in any of the detergents tested (DDM, DM,
LDAO or C12E8) and so work on PFZIP was discontinued. It is possible that the high levels of
expression and the lack of solubilisation are linked: i.e. PFZIP is denatured.
With AXZIP, the highest levels of expression (~2.6 mg/L culture) came from pL21-AXZIP
using 24 h auto-induction at 37°C in LB medium in E. coli BL21 Star (DE3):pRARE2 (Fig 3A).
Both the MntH2 variants and pL21-AXZIP could be successfully purified by IMAC on
cobalt resin, MntH2 in DDM, yielding 1–2 mg protein/L; and pL21-AXZIP in DM, yielding
~ 0.5 mg protein/L. All yielded a single major Coomassie Blue-staining band on SDS-PAGE of
the appropriate molecular mass (Fig 3C). With AXZIP, there were less intense bands of appar-
ent sizes ~60 kDa and 90 kDa (Fig 3C) that, based on western blotting, appear to correspond to
monomeric, dimeric and trimeric forms of the protein. Purification of AXZIP to homogeneity
was thus successful.
Conversely, some of the MntH2 preparations contained a minor contaminant of apparent
size ~100 kDa (Fig 4B), which is probably due to the endogenous membrane protein AcrB
[45]. To remove it, pL32-MntH2 protein was treated for 18 h at 4°C with TEV protease at
Fig 2. Schematic representation of the constructs used in this study is depicted in the panel above. The summary of the constructs details is shown in
the table of the panel below.
doi:10.1371/journal.pone.0143010.g002
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molar ratios of protease: MntH2 of up to 2.5:1. However, western blotting revealed that the His
tag remained attached to the protein (data not shown). In contrast, incubation of the
pL33-MntH2 protein with 2 equivalents of HRV-3C protease yielded essentially complete
cleavage after 24 h (Fig 4B). Surprisingly, the cleaved protein was retained on the IMAC col-
umn during re-chromatography (data not shown), but it could be separated from uncleaved
MntH2 protein by SEC on a Superdex 200 column, in which the cleaved protein migrated as a
single, symmetrical included peak indicative of monodispersity (Fig 4C). SEC-MALLS analysis
of the uncleaved protein gave a molecular mass of 65.4 kDa, consistent with it being a mono-
mer in detergent solution (data not shown).
Protein characterisation and activity measurements for MntH2 and AXZIP. We used
two approaches to determine if the purified proteins were in their native folded state: their CD
spectra and melting curves, and activity measurements. For both MntH2 (Fig 4A) and AXZIP
(data not shown), CD spectra revealed the presence of two major negative bands, at ~ 208 nm
and ~ 220 nm, indicative of α-helical structure [47]. The program SELCON3 (Sreerama and
Woody 1993) predicted that MntH2 was 81.0% ± 0.2% α-helix, and 21.4% ± 0.7% turns plus
random coil, as expected for a membrane protein. Heating MntH2 resulted in progressive loss
of α-helical structure at increasing temperatures (Fig 4B), yielding an estimated melting tem-
perature of 62.1 ± 6.0°C.
We reconstituted purified MntH2 and AXZIP into proteoliposomes and used quenching of
cation-specific fluorophores (see Materials and Methods) to measure their transport of divalent
cations. MntH2 did not transport Mn2+ (data not shown), based on quenching of encapsulated
calcein, which has been used to measure Mn2+ transport [48]. However, as other members of
the Nramp family transport various divalent metal cations, including Zn2+ [49,50], we tested
Zn2+ transport using the Zn2+-sensitive fluorescent dye “FluoZin™-1”. Proteoliposomes con-
taining purified MntH2 took up Zn2+ much faster than protein-free liposomes, and the rate
Fig 3. (A) Western blot analysis of expression levels yielded by 3 different His-tagged MntH2 constructs. The indicated constructs in E. coli strain
BL21 Star™ (DE3) cells harbouring pRARE2 were autoinduced for 24 h as detailed in the text and then cell lysates analysed by SDS-PAGE/
western blotting. Each lane contained 20 μg total protein. The amounts of His-tagged TEV protease standards blotted in parallel are indicated. The
blot was stained for the presence of oligohistidine tags with HRP-labelled monoclonal anti-6 × polyhistidine antibody. The mobilities of marker
proteins of knownmolecular mass are shown on the left. (B) Western blot analysis of samples from expression trials performed using
pL21-AXZIP. Expression was performed in E. coli strains BL21Star either with IPTG induction (IPTG) or autinduction for amount of times indicated
under the figure. The blot was stained with HRP-labelled monoclonal anti-6 × polyhistidine antibody. (C) Purification of MntH2 and AXZIP. Purified
proteins were loaded on a gel and either stained with Coomassie Blue (Co) or transferred on a nitrocellulosemembrane and stained with anti-His
antibody (IB).
doi:10.1371/journal.pone.0143010.g003
Production of Membrane Proteins with Diverse Topologies
PLOS ONE | DOI:10.1371/journal.pone.0143010 November 25, 2015 12 / 23
Production of Membrane Proteins with Diverse Topologies
PLOS ONE | DOI:10.1371/journal.pone.0143010 November 25, 2015 13 / 23
depended on Zn2+ concentration (Fig 5A). Zn2+ uptake was too rapid, even at 4°C, to allow
accurate estimation by stopped flow fluorimetry of the initial rate of uptake, precluding deter-
mination of the kinetic parameters of transport (Fig 5B).
In AXZIP-containing proteoliposomes, the rise in ΔF/ΔFmax with time (data not shown) is
much faster than for control proteoliposomes, indicating that AXZIP is specific for Zn2+
uptake. The initial rate of fluorescence change had a linear dependence on extravesicular zinc
concentration, with no evidence of saturation up to the maximum concentration investigated
(2 mM) (Fig 5C and 5D), suggesting that AXZIP, like ZIPB, may be a Zn2+ channel [51].
Expression and purification of transporters where both termini are non-
cytoplasmic
Both termini being non-cytoplasmic precludes the use of simple His-tags. We therefore
adopted two tagging strategies: first, as a single periplasmic Strep-tag II is compatible with high
level expression of E. coliMntH2 [13], we added tandem Strep-tag II sequences to the C-ter-
mini of the proteins (expression vectors pL40 and pL41). Second, we added a His-tag to the N-
terminus of the proteins between the MBP and the signal sequence (expression vector pL53),
so that the N-terminus is correctly directed to the periplasmic side of the membrane. We tested
these new vectors for CBZIP and for two CNT family transporters, all of which have Nout-Cout
topologies.
Initial attempts at purification of CBZIP employed the construct pL40-CBZIP, which has
two tandem Strep-tag II sequences at the C-terminus. However, while this construct could suc-
cessfully be expressed at a level of ~ 3.4 mg/L culture following autoinduction for 24 h at 37°C
in SB medium using E. coli strain C43(DE3): pRARE2 as host, we could not solubilise and
purify it. pL53-CBZIP, with the N-terminal MBP-His8 tag (Fig 2) yielded up 14 mg/L culture
by autoinduction for 24 h in LB medium in E. coli BL21 Star™ (DE3) pRARE2 (Fig 6A). The
tagged protein could be successfully purified by IMAC on cobalt resin in DM, with a yield of
~ 1.3 mg protein/L culture. The major band on Coomassie Blue -stained SDS-PAGE had an
apparent size ~70 kDa, consistent with the predicted molecular mass of 73.7 kDa for the tagged
protein lacking a signal sequence, together with minor bands of higher and lower apparent
molecular mass (Fig 6B). Most of the latter, like the ~70 kDa band, is also stained with antibod-
ies against the His tag, suggesting that they corresponded to oligomeric forms and degradation
products of CBZIP respectively (Fig 6B).
Constructs encoding simple C-terminally His-tagged forms of E. coli NupC did not express
at all. We therefore turned to vectors pL40, pL41, pL53 and pL55 (Fig 2) to express and purify
both E. coli NupC and its homologue VcCNT from V. cholerae.
Fig 4. (A) Analysis of the secondary structure of His-tagged MntH2, expressed from construct pL33-MntH2, by circular dichroism spectroscopy
(top pannel). The analysis of the spectrum using the SELCON3 algorithm indicated that the composition were 81.0% ± 0.2% α-helix, 0.5% ± 0.3% β-
sheet and 21.4% ± 0.7% turns plus random coil. The thermal stability of MntH2 (Bottom pannel). IMAC purified pL33-MntH2 (0.125 mg/mL) was
dissolved in 50 mMMES buffer, pH 6.0 containing 5% glycerol and 0.05%DDM. Thermal stability wasmeasured by ramping the temperature from
10°C to 90°C, at a rate of 1°C per second. CDmeasurements were performed at 222 nm following each 1°C increase in temperature, and are plotted
following correction for the buffer blank. The solid line shows a non-linear fit of these data to the Boltzmann equation. (B) Purification steps of
MntH2. Pure MntH2 protein before (P) or after cleavage with HRV3C (C) was loaded on a gel and either stained with Coomassie Blue (Co) or
transferred on a membrane and immunoblotted with anti-His antibody (IB). (C) Separation of HRV-3C protease-cleaved MntH2 from the protease
by size-exclusion chromatography. Left panel: A280nm profiles of the HRV-3C protease-cleaved MntH2 on a Superdex 200 10/300 column (“MntH2
cleaved with HRV”, solid blue line) and of HRV-3C protease alone (“HRV”, dotted green line). Right panel: Samples containing 20 μg of MntH2
before and after cleavage with HRV-3C protease, and of the indicated peak fractions from the elution profile (40 μL) were subjected to SDS-PAGE
and then either stained with Coomassie blue (top) or transferred to nitrocellulosemembrane and stained for the presence of oligohistidine tags
with HRP-labelled monoclonal anti-6× polyhistidine antibody (bottom). The mobilities of marker proteins of knownmolecular mass (kDa) are
shown on the left.
doi:10.1371/journal.pone.0143010.g004
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Both the double Strep-tag II and the HisMBP constructs gave equivalent expression levels
(Fig 6C for double Strep-tag II, not shown for MBP). We chose to focus on expression using
the HisMBP constructs, as the resin needed for purification costs less. The level of expression
Fig 5. Comparison of zinc uptake by protein-free liposomes and proteoliposomes containing either MntH2 or AXZIP. (A) Liposomes and
MntH2-containing proteoliposomes containing 200 μM FluoZin™-1 were mixed with zinc-containing assay buffer to yield a final [Zn2+] of 2 mM, and the
resultant fluorescence changes recorded using a stopped flow fluorimeter. The normalized fluorescence change (ΔF/ΔFmax) was determined by dividing the
observed fluorescence change (ΔF) by that induced by adding 1% β-OG to the extravesicular medium (ΔFmax). The results shown are the means of three
measurements. (B) Fluorescent assays of zinc uptake were performed as described in the legend above, except that the extravesicular concentration of Zn2+
was varied from 100 μM to 1 mM. (C) same as in (B) but with AXZIP proteoliposomes and a Zn2+ concentration was from 50 μM to 2 mM (D) Initial rates of
zinc uptake versus the extravesicular zinc concentration was subjected to linear regression. Initial rates (s-1) were estimated by fitting the first five data points
(0–0.1 s) for each Zn2+ concentration in (C). All the results shown are the means of three measurements ± standard deviation.
doi:10.1371/journal.pone.0143010.g005
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of the HisMBP constructs depended on the promoter: both NupC and VcCNT expressed better
from a T7 promoter than expression from a ptac promoter (Fig 6E: the pL55 plasmid). We
thus used protein expressed from the pL55 plasmids for further purification. These express
either NupC or VcCNT under the T7 promoter and with an N-terminal HisMBP HRV tag. For
NupC, the pL55 plasmid was compared with the pL41 plasmid expressing the double Strep-tag
II NupC construct. We could purify and remove the affinity tags by protease digestion (Fig 6).
Fig 6. (A) Expression tests of pL53-CBZIP in various strains: C41, C43, BL21 Star (S) or BL21 Gold (G). Total extracted were loaded on a gel and
stained with Coomassie Blue. (B) pL53-CBZIP was expressed in BL21 Star (S) and purified with an affinity column. Pure CBZIP was loaded on a gel
and stained with Coomassie Blue (Co) or transferred onto a membrane and immunoblotted with Anti-His antibody (IB). (C) Expression test of
p40-NupC. Cells expressing NupC were induced with IPTG. After 3h induction, cells were lysed by water-lysis technique as described in material
andmethods, loaded on a gel and stained with Coomassie Blue (I). Uninduced cells were loaded as a control (C). (D) Purified NupC protein was
loaded on gel before (P) and after cleavage by TEV (C), and submitted to a negative purification to remove His-TEV and collect NupC in the flow
through (F). Comparison between Coomassie Blue (Co) stained and immunoblot (IB) with antiHis Antibody is shown. The size of the purified
protein (P) or the TEV protein (T) is shown on the right. (E) Effect of promoter on expression of NupC and VcCNT. Whole cellular extracts
expressing NupC or VcCNT on either a pL53 (ptac promoter) or pL55 vector (T7 promoter). (F) Purification of NupC and VcCNT as described in (D).
doi:10.1371/journal.pone.0143010.g006
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TEV efficiently cleaved off the double Strep-tag II, so after cleavage, anti-Strep antibody no lon-
ger detects purified NupC while the Strep-tag II tagged TEV protease is still detected (Fig 6D),
and we could remove the TEV protease completely by a second Streptactin purification step,
where the purified cleaved protein, which is in the flow through, is not detectable by an anti-
body against the Strep tag II sequence (Fig 6D). Similarly, both the pL55-expressed NupC and
VcCNT were cleaved efficiently by the His-HRV protease, and the cleaved protein is in the
flow through of the second Ni-NTA purification (Fig 6F).
Activity of CBZIP and CNTs
We used activity assays to determine whether these proteins, with both termini extracellular,
were correctly folded and inserted into the membrane. For CBZIP, its ability to transport zinc
was measured as for AXZIP, following reconstitution of the purified protein into proteolipo-
somes. As expected, the rate of Zn2+ uptake into proteoliposomes harbouring the purified pro-
tein was substantially greater than for protein-free liposomes (S2A Fig). We also tested uptake
of Cd2+ and Ni2+ using the same assay but with CdCl2 or NiCl2 at a final concentration of 2
mM (S2B and S2C Fig).
Both Ni2+ and Cd2+ enhance the fluorescence of the indicator in a fashion similar to that of
Zn2+, indicating that they represent alternative substrates for CBZIP. We could not measure
the transport of Mg2+ nor of Mn2+ directly, because neither substantially enhanced the fluores-
cence of FluoZin™-1 (data not shown). However, at a concentration of 2 mM neither metal ion
decreased the fluorescence response of MntH2 proteoliposomes containing FluoZin™-1 to 2
mM ZnCl2 for a period of 2 min (S2C Fig). This apparent lack of competition for uptake sug-
gests that neither metal ion is a substrate of the transporter.
Kinetic analysis of Zn2+ uptake into proteoliposomes containing AXZIP suggested it may be
a channel rather than a transporter (Fig 5D). As CBZIP is only distantly related to AXZIP, we
wanted to determine if it likewise exhibited such channel-like behaviour, even though ZIP fam-
ily proteins are designated as transporters rather than channels. We therefore measured the ini-
tial rate of zinc influx at different extravesicular zinc concentrations. The initial rate of
fluorescence change depended linearly on the Zn2+ concentration, with no evidence of satura-
tion up to the maximum concentration investigated (2 mM) (Fig 7A). This behaviour resem-
bled that both of AXZIP and ZIPB [51].
We used a different set of assays to determine if the CNTs were correctly folded because
there is no convenient assay for CNTs reconstituted into proteoliposomes. The CD spectra of
NupC purified from pL41 (data not shown) and pL55 (Fig 7C), and of VcCNT (data not
shown) all suggested that the purified proteins were correctly folded as they were essentially all
α-helical: both the double Strep-tag II or and HisMBP tag allowed expression and purification
of folded transporters. We also verified if the tagged proteins were functional before purifica-
tion by studying the transport activity of StrepNupC (pL41), HisMBP NupC (pL55) (Fig 7D)
and HisMBP VcCNT (not shown) in whole cells (Fig 7D). It is clear that the double Strep-tag II
NupC (pL41-NupC) is almost three times more active than HisMBP NupC (pL55-NupC)
(Fig 7D). Nonetheless, the HisMBP tagged protein expressed from a T7 promoter seems to be
better suited for further biophysical studies because the expression level of the protein is greater
(Fig 6).
Discussion
Historically, proteins with either one or two termini in the periplasm have proven difficult to
purify due to probable alteration of expression and/or folding of proteins by the conventional
poly-histidine tags. We decided to investigate this issue by using a combination of strains,
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vectors, tags and proteases to yield pure and functional proteins suitable for biophysical studies.
The proteins chosen have important biological activities and have either one or both termini in
the periplasm.
The first family selected is a putative Manganese transporter MntH. The promoter region of
the MntH gene possesses a binding motif for the Mn2+-sensitive transcriptional regulator EfaR,
and Mn2+ has been found to downregulate transcription of the gene [26], consistent with its
putative function in manganese transport. Human members of this family possess a cyto-
plasmic N-terminal and a periplasmic C-terminal. As for the ZIP family, some submembers
possess an extra TM which flips the C-terminal back in the cytosol. Although no structural
information is available for MntH2, or indeed for any other member of the Nramp family, it
forms part of the Pfam Clan APC (CL0062), the amino acid-polyamine-organocation super-
family of transporters [52]. The structures of several such transporters have been solved, reveal-
ing them to possess duplicated inverted domains, each with five TM α−helices [52]. A model
of MntH2 based on the structure of the proton-coupled amino acid transporter ApcT [53]
exhibits an α-helix content of 75% (data not shown), consistent with the figure of 81.0% α-
helix revealed by CD spectroscopy of the purified protein. Protein purification to homogeneity
and demonstration of its monodispersity by SEC now opens up the way for more detailed
examination of the MntH2 structure by X-ray crystallography and other approaches.
The ZIP family members we have investigated belong to two distinct subfamilies: subfamily
II (CBZIP) and the GufA subfamily (PFZIP and AXZIP). Although PFZIP could not be puri-
fied in an active form, AXZIP and CBZIP were successfully expressed, purified and reconsti-
tuted in proteoliposomes. Both proteins are able to mediate significantly higher zinc influx
compared to empty liposomes. Additionally, preliminary data suggest that CBZIP mediates
bidirectional transport of zinc, depending on the membrane potential (Fig 7B). This is in agree-
ment with the channel activity found for ZipB, a bacterial member of the GufA subfamily, and
confirms that the ZIP family contains both transporters and channels.
Similarly, following the same methodology and despite their Nout-Cout topology, the con-
centrative nucleoside transporters (NupC and VcCNT) were purified and shown to be to be
folded, stable and active. In addition, we determined that the best expression-tag combination
is an N-terminally His-MBP-HRV-3C tagged protein expressed from a T7 promoter. The
HRV-3C protease has the advantage over the TEV protease in that it can work at 4°C and in
the presence of a wide variety of detergents [54]. It is thus more suitable for membrane protein
purification. The choice of expression strains and growing media conditions (temperature/
media) should however be adapted to each membrane protein as this can vary from one to the
other.
This paper describes the development of a series of new vectors and general strategies for
the expression and purification of various membrane proteins where either one or both termini
are extracellular. We show that by using a limited combination of tags and proteases (TEV or
HRV-3C), we can purify five out of six proteins to homogeneity in an active, folded form. We
Fig 7. (A) Concentration dependence of Zn2+ uptake by proteoliposomes containing CBZIP. Fluorescent assays of zinc uptake were performed as
described in Fig 5D with extravesicular Zn2+ concentration from 50 μM to 2 mM. (B) Membrane potentials drive bidirectional zinc fluxes. The effect
on the fluorescence of encapsulated FluoZin™-1 caused by dilution of CBZIP proteoliposomes containing 100mMK+ and 50 μM Zn2+ into medium
containing 50 μM Zn2+ with varying K+ concentrations as indicated. (C) Analysis of the secondary structure of NupC expressed from construct
pL55 by circular dichroism spectroscopy. The analysis of the spectrum using the SELCON3 algorithm indicated that the composition were 81.0%
± 0.2% α-helix, 0.5% ± 0.3% β-sheet and 21.4% ± 0.7% turns plus random coil. Thermal stability wasmeasured by ramping the temperature from
10°C to 90°C, at a rate of 1°C per second. CDmeasurements were performed at 222 nm following each 1°C increase in temperature, and are plotted
following correction for the buffer blank. The solid line shows a non-linear fit of these data to the Boltzmann equation. (D) Transport assay by
NupC. Radioactively labelled Uridine import wasmeasured on intact cells expressing NupC from either pL55 or pL40. Transport was stopped after
15s or 120s by filtration has described in material andmethods. As a control, mock cells were also tested (control).
doi:10.1371/journal.pone.0143010.g007
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believe that these tools and approaches will prove generically useful in the production of pro-
karyote membrane proteins for subsequent biochemical and biophysical studies.
Supporting Information
S1 Fig. Phylogenetic tree of ZIP family members. All family members from A. thaliana (At,
green), H. sapiens (Hs, blue) and S. cerevisiae (Sc red) are included, together with examples of
eubacterial family members (magenta), archaeal family members (orange) and a second exam-
ple of a fungal Zip I subfamily member. UniProt accession numbers are as follows: HsZIP1,
Q9NY26; HsZIP2, Q9NP94; HSZIP3, Q9BRY0; HsZIP4, Q6P5W5; HsZIP5, Q6ZMH5;
HsZIP6, Q13433; HsZIP7, Q92504; HsZIP8, Q9C0K1; HsZIP9, Q9NUM3; HsZIP10, Q9ULF5;
HsZIP11, Q8N1S5; HsZIP12, Q504Y0; HsZIP13, Q96H72; HsZIP14, Q15043; AtIRT1,
Q38856; AtIRT2, O81850; AtIRT3, Q8LE59; AtZIP1, O81123; AtZIP2, Q9LTH9; AtZIP3,
Q9SLG3; AtZIP4, O04089; AtZIP5, O23039; AtZIP6, O64738; AtZIP7, Q8W246; AtZIP8,
Q8S3W4; AtZIP9, O82643 (corrected for misidentification of start codon); AtZIP10, Q8W245;
AtZIP11, Q94EG9; AtZIP12, Q9FIS2; AtIAR1, Q9M647; AtZTP29, Q940Q3; ScZRT1, P32804;
ScZRT2, Q12436; ScZRT3, P34240; ScATX2, Q12067; ScYKE4, P40544; EnZIP (Emericella
nidulans) Q5AZR4; CBZIP (Coxiella burnettii), Q83BJ7; RsZIP (Ralstonia solanacearum)
B5S1Z4; MxGufA (Myxococcus xanthus) Q06916; EcZupT (Escherichia coli), P0A8H3; ZIPB
(Bordetella bronchiseptica), Q7WJT8; PFZIP (Pseudomonas fluorescens), Q4K7I2; GSZIP (Geo-
bacter sulfurreducens), Q74GP0; DVZIP (Desulfovibrio vulgaris), Q72WF3; AXZIP (Achromo-
bacter xylosoxidans), V9S2P1; MlZIP (Methanofollis liminatans), J1L0Y0; FpZIP (Ferroglobus
placidus), D3RXQ7.
(TIF)
S2 Fig. Zn2+ uptake by proteoliposomes containing MntH2. Three fluorescent repeats of
zinc uptake were performed as described in Fig 5D with extravesicular Zn2+ concentration of
1 mM. (B) Comparison of Zn2+ uptake by empty proteoliposomes (red line), NupC-(green
line) or MntH2-(Blue line) containing proteoliposomes in the presence of 250 μMZn2+ as
compared to uptake by MntH2- containing proteoliposomes (Black line) in the absence of 0
uM Zn2+.
(TIFF)
S3 Fig. CBZIP transport properties of divalent cation (A) Comparison of zinc uptake by pro-
tein-free liposomes and proteoliposomes containing CBZIP. Liposomes (control) and proteoli-
posomes (CBZIP) containing 200 μM FluoZin™-1 were mixed with zinc-containing assay
buffer to yield a final [Zn2+] of 2 mM, and the resultant fluorescence changes recorded using a
stopped flow fluorimeter. The normalized fluorescence change (ΔF/ΔFmax) was determined by
dividing the observed fluorescence change (ΔF) by that induced by adding 1% β-OG to the
extravesicular medium (ΔFmax). Stopped flow fluorescence measurements were made using an
excitation wavelength of 490 nm and emission was monitored using a filter with a cut-off wave-
length of 515 nm. The results shown are the means of three measurements. (B) CBZIP-medi-
ated Ni2+ transport. Liposomes (control) and proteoliposomes (CBZIP) containing 200 μM
FluoZin™-1 were mixed with nickel-containing assay buffer to yield a final [Ni2+] of 2 mM, and
the resultant fluorescence changes recorded using a stopped flow fluorimeter. The normalized
fluorescence change (ΔF<Ni>/ΔFmax<Ni>) was determined by dividing the observed fluores-
cence change (ΔF) by that induced by adding 1% β-OG to the extravesicular medium. Stopped
flow fluorescence measurements were made using an excitation wavelength of 490 nm and
emission was monitored using a filter with a cut-off wavelength of 515 nm. The results shown
are the means of three measurements. (C) BZIP-mediated Cd2+ transport. Experiments were
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performed the same as described in (A), except cadmium-containing assay buffer was used
here. (D) Apparent effects of other divalent metal ions on CBZIP-mediated transport of 2 mM
Zn2+. Uptake experiments on proteoliposomes reconstituted with CBZIP were initiated by
adding 2 mM ZnCl2 (final concentration) alone or with the indicated concentrations of other
divalent metal ions. Fluorescence changes (ΔF) relative to the addition of buffer alone was mea-
sured using a fluorimeter (Photon Technology International) using an excitation wavelength of
490 nm and an emission wavelength of 515 nm. The results shown are the means of three
measurements ± standard deviation. The significance of the differences between the “No addi-
tive” and other samples were analyzed by “OneWay ANOVA” and are indicated as “” when
p<0.01.
(TIF)
S1 Table. Oligonucleotides used in this study.
(DOCX)
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